Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of Jul 07
 +0.93 / +1.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 103.00, with a high estimate of 125.00 and a low estimate of 92.00. The median estimate represents a +20.10% increase from the last price of 85.76.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.75%
Growthannually -80.60%


Growthquarterly --
Growthannually -100.00%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account